Oxygen Biotherapeutics Liabilities:
4.643M for Jan. 31, 2013Oxygen Biotherapeutics Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Jan. 31, 2013 | 4.643M |
| Oct. 31, 2012 | 3.600M |
| July 31, 2012 | 5.768M |
| April 30, 2012 | 4.488M |
| Jan. 31, 2012 | 6.762M |
| Oct. 31, 2011 | 8.274M |
| July 31, 2011 | 7.794M |
| April 30, 2011 | 6.647M |
| Jan. 31, 2011 | 3.746M |
| Oct. 31, 2010 | 1.466M |
| July 31, 2010 | 1.280M |
| April 30, 2010 | 1.402M |
| Jan. 31, 2010 | 1.199M |
| Oct. 31, 2009 | 1.652M |
| July 31, 2009 | 0.5688M |
| April 30, 2009 | 0.7015M |
| Jan. 31, 2009 | 1.792M |
| Oct. 31, 2008 | 1.746M |
| July 31, 2008 | 1.679M |
| April 30, 2008 | Go Pro |
| Jan. 31, 2008 | Go Pro |
| Oct. 31, 2007 | Go Pro |
| July 31, 2007 | Go Pro |
| April 30, 2007 | Go Pro |
| Jan. 31, 2007 | Go Pro |
| Oct. 31, 2006 | Go Pro |
| July 31, 2006 | Go Pro |
| April 30, 2006 | Go Pro |
| Jan. 31, 2006 | Go Pro |
| Oct. 31, 2005 | Go Pro |
| July 31, 2005 | Go Pro |
| April 30, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
| Jan. 31, 2004 | Go Pro |
| Oct. 31, 2003 | Go Pro |
| July 31, 2003 | Go Pro |
| April 30, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
| Oct. 31, 2000 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
OXBT Liabilities Benchmarks
| Companies | |
|---|---|
| Opexa Therapeutics | 1.263M |
| ARCA biopharma | 0.305M |
| Bioline Rx | 10.46M |
OXBT Liabilities Rankings
| Overall |
92nd percentile 554 of 7593 |
| Sector |
83rd percentile 110 of 650 in Healthcare |
| Industry |
78th percentile 50 of 237 in Biotechnology |
OXBT Liabilities Range, Past 5 Years
| Minimum | 0.5688M | Jul 2009 |
| Maximum | 8.274M | Oct 2011 |
| Average | 3.432M |
